This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Formed in 2007 by the merger of the Chicago Mercantile Exchange (CME) and the Chicago Board of Trade (CBOT), CME Group is the largest futures exchange in the world in terms of trading volume as well as notional value traded. The Chicago Mercantile Exchange was originally formed as a non-profit organization in 1898, but was converted to a for-profit company in 2000. It became the first publicly traded financial exchange in the U.S. in Dec 2002. CBOT, established in 1848, is a leading futures and options exchange. In Apr 2005, CBOT converted into a for-profit stock-based holding company and for-profit membership exchange subsidiary.
Exchanges Are a Buy as Trade War Tensions Heighten
by Daniel Laboe
Trade war tensions are growing between the world's two largest economies, as both China and the US take more aggressive stances. As the broader market sells-off investors will flock to safe-havens such as low beta stocks, gold, and fixed income investments.
New Strong Sell Stocks for May 8th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.
Cboe Global's (CBOE) Q1 Earnings Beat Estimates, Down Y/Y
by Zacks Equity Research
Cboe Global's (CBOE) first-quarter earnings gain on the back of lower expenses, partly offset by soft revenues.
Intercontinental Exchange (ICE) Q1 Earnings & Revenues Beat
by Zacks Equity Research
Intercontinental Exchange (ICE) Q1 reflects growth in subscription-based Data & Listings business, which offset muted trading activity.
CME Group (CME) Q1 Earnings Surpass Estimates
by Zacks Equity Research
CME (CME) delivered earnings and revenue surprises of 1.25% and -1.01%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
CME Group (CME) Q1 Earnings Beat, Revenues Miss Estimates
by Zacks Equity Research
CME Group (CME) Q1 reflects low levels of volatility in several products. However, product innovation and a growing proportion of volume outside the United States helped.
Should You Invest in the iShares U.S. Broker-Dealers & Securities Exchanges ETF (IAI)?
by Sweta Killa
Sector ETF report for IAI
CME Group (CME) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
CME Group (CME) is likely to benefit from expansion of futures products in emerging markets, options business, non-transaction related opportunities and OTC offerings.
Analysts Estimate CME Group (CME) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
CME (CME) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nasdaq (NDAQ) Posts Mixed Q1 Volumes, March ADV Disappoints
by Zacks Equity Research
Nasdaq (NDAQ) is poised for long-term growth given continued improvement at index and analytics businesses followed by moderate exchange data products operations.
Intercontinental Exchanges (ICE) March Volume Improves Y/Y
by Zacks Equity Research
Intercontinental Exchange's (ICE) March volume reflects improved Financial ADV partially offset by decline in Commodities ADV.
Should You Invest in the iShares U.S. Broker-Dealers & Securities Exchanges ETF (IAI)?
by Zacks Equity Research
Sector ETF report for IAI
Cboe Global (CBOE) Posts Weak March Volumes, Guides Q1 RPC
by Zacks Equity Research
Cboe Global (CBOE) suffers low trading volumes in March with both options and futures ADV witnessing a year-over-year drop.
CME Group's (CME) Q1 ADV Down Y/Y, March Volumes Disappoint,
by Zacks Equity Research
CME Group (CME) witnessed lower average daily volumes for both first quarter and March 2019 as volumes declined across all six product line for both the periods.
Here's Why You Should Hold on to CME Group (CME) Stock Now
by Zacks Equity Research
CME Group (CME) is poised for growth, given higher clearing and transaction fees, expense management, and strong capital management policy.
Why Is CME (CME) Down 4.1% Since Last Earnings Report?
by Zacks Equity Research
CME (CME) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
CME Group (CME) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, CME Group (CME) closed at $170.14, marking a +1.02% move from the previous day.
Should You Invest in the iShares U.S. Broker-Dealers & Securities Exchanges ETF (IAI)?
by Sweta Killa
Sector ETF report for IAI
Cboe Global (CBOE) February Volumes Disappoint, Down Y/Y
by Zacks Equity Research
Cboe Global (CBOE) suffers low trading volumes in February with both options and futures ADV witnessing a year-over-year drop.
CME Group (CME) February ADV Drops at Six Products Lines
by Zacks Equity Research
CME Group's (CME) average daily volume for February dropped as volumes declined across all its six product lines.
The Zacks Analyst Blog Highlights: United Parcel, Morgan Stanley, CME, Williams and Enbridge
by Zacks Equity Research
The Zacks Analyst Blog Highlights: United Parcel, Morgan Stanley, CME, Williams and Enbridge
Top Research Reports for United Parcel Service, Morgan Stanley & CME Group
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including United Parcel Service (UPS), Morgan Stanley (MS) and CME Group (CME).
CME Group (CME) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
CME Group (CME) Q4 reflects increased volatility and higher customer demand for diverse risk management products driving strong trading volumes.
CME Group (CME) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
CME (CME) delivered earnings and revenue surprises of 1.14% and 6.56%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
5 Stocks with Fantastic Earnings Charts
by Tracey Ryniec
These companies have great earnings surprise track records. Will they do it again this quarter?